InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
0.8070
-0.0081 (-0.99%)
At close: Aug 8, 2025, 4:00 PM
0.8165
+0.0095 (1.18%)
After-hours: Aug 8, 2025, 7:53 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Monoclonal Antibodies
68.21K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
68.21K